It Is Time to Address the Crisis in the Pharmacotherapy of Posttraumatic Stress Disorder: A Consensus Statement of the PTSD Psychopharmacology Working Group

Affiliations

• ¹ Departments of Psychiatry and Neuroscience, Yale University School of Medicine, New Haven; Clinical Neuroscience Division, National Center for PTSD, West Haven, Connecticut; Psychiatry Services, VA Connecticut Healthcare System, West Haven, Connecticut. Electronic address: john.krystal@yale.edu.
• ² Development Service, Tuscaloosa VA Medical Center, Tuscaloosa; Department of Psychiatry, University of Alabama School of Medicine, Birmingham, Alabama.
• ³ Department of Psychiatry, University of California, San Francisco; San Francisco VA Medical Center, San Francisco.
• ⁴ Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington; VA Puget Sound Health Care System, Seattle, Washington.
• ⁵ Executive Division, National Center for PTSD, White River Junction, Vermont; Department of Psychiatry, Geisel School of Medicine at Dartmouth, White River Junction, Vermont.
• ⁶ Departments of Psychiatry and Family Medicine & Public Health, University of California, San Diego, La Jolla; VA San Diego Healthcare System, San Diego, California.
• ⁷ Clinical Neuroscience Division, National Center for PTSD, West Haven, Connecticut; Psychiatry Services, VA Connecticut Healthcare System, West Haven, Connecticut.
• ⁸ Departments of Psychiatry and Neuroscience, Yale University School of Medicine, New Haven.
• ⁹ Department of Veterans Affairs, Office of Research & Development, Washington, DC; Cooperative Studies Program Central Office, VA Office of Research and Development, Washington, DC.